Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes-Reference-Cited by-同舟云学术

Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes

Published:2017-12 Issue:12 Volume:7 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Tang Y-T,Wang D,Luo H,Xiao M,Zhou H-S,Liu D,Ling S-P,Wang N,Hu X-L,Luo Y,Mao X,Ao Q-L,Huang J,Zhang W,Sheng L-S,Zhu L-J,Shang Z,Gao L-L,Zhang P-L,Zhou M,Zhou K-G,Qiu L-G,Liu Q-F,Zhang H-Y,Li J-Y,Jin J,Fu L,Zhao W-L,Chen J-P,Du X,Huang G,Wang Q-F,Zhou J-F,Huang L^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-017-0021-z.pdf

Reference15 articles.

1. Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 127, 2375–2390 (2016).

2. Kwong, Y. L. et al. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 10, 1093–1101 (2009).

3. Suzuki, R. et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18, 763–770 (2004).

4. Kimura, H. et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119, 673–686 (2012).

5. Takahashi, E. et al. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology 59, 660–671 (2011).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV-positive Nodal T-Cell and NK-Cell Lymphoma;American Journal of Surgical Pathology;2024-01-30

2. Acute and Persistent Remission of Aggressive Natural Killer Cell Leukemia in an Older Patient Induced by Chidamide Combined with Cyclophosphamide, Vindesine, Prednisone, and Etoposide Therapy;Turkish Journal of Hematology;2023-09-01

3. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment;International Journal of Molecular Sciences;2023-07-28

4. Not all LGL leukemias are created equal;Blood Reviews;2023-07

5. Clinical and genetic characterization of Epstein-Barr virus–associated T/NK-cell lymphoproliferative diseases;Journal of Allergy and Clinical Immunology;2023-04